Showing results (221-230 of 296) with videos related to

Sort By:
Pageof 30
Journal of Neurology, Neurosurgery, and Psychiatry|January 19, 2024
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase RegistryAlessio Signori, Marta Ponzano, Tomas Kalincik, et al.
Journal of Neurology|June 19, 2019
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort studyJessica Frau, Francesco Saccà, Alessio Signori, et al.
Journal of the International AIDS Society|November 15, 2014
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mLChiara Dentone, Daniela Fenoglio, Alessio Signori, et al.
American Journal of Hematology|November 4, 2020
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimenPatrizia Chiusolo, Stefania Bregante, Sabrina Giammarco, et al.
Journal of Chemotherapy (Florence, Italy)|August 20, 2024
COVID-19 throughout pandemic waves and virus variants: a real-life experience in an Italian hospitalSilvia Dettori, Giorgia Brucci, Federica Portunato, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2024
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoringMalgorzata Mikulska, Monica Melchio, Alessio Signori, et al.
European Journal of Clinical Investigation|June 15, 2020
Bloodstream infections in critically ill patients with COVID-19Daniele Roberto Giacobbe, Denise Battaglini, Lorenzo Ball, et al.
Immunotherapy|August 19, 2024
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumabAlessandra Damassi, Malvina Cremante, Alessio Signori, et al.
Minerva Urology and Nephrology|October 23, 2025
The added value of PSMA PET to nomograms in identifying optimal candidates for extended pelvic lymph node dissection in intermediate-risk prostate cancer patientsMatteo Bauckneht, Enrico Checcucci, Francesco Lanfranchi, et al.
Pageof 30